SE0400564D0 - Methods - Google Patents

Methods

Info

Publication number
SE0400564D0
SE0400564D0 SE0400564A SE0400564A SE0400564D0 SE 0400564 D0 SE0400564 D0 SE 0400564D0 SE 0400564 A SE0400564 A SE 0400564A SE 0400564 A SE0400564 A SE 0400564A SE 0400564 D0 SE0400564 D0 SE 0400564D0
Authority
SE
Sweden
Prior art keywords
methods
clca
modulating
diseases
treat
Prior art date
Application number
SE0400564A
Other languages
English (en)
Inventor
Matti Lepistoe
Krzysztof Pawlowski
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0400564A priority Critical patent/SE0400564D0/sv
Publication of SE0400564D0 publication Critical patent/SE0400564D0/sv
Priority to PCT/SE2005/000316 priority patent/WO2005085868A1/en
Priority to EP05711171A priority patent/EP1725875A1/en
Priority to US10/590,691 priority patent/US20080233604A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE0400564A 2004-03-05 2004-03-05 Methods SE0400564D0 (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE0400564A SE0400564D0 (sv) 2004-03-05 2004-03-05 Methods
PCT/SE2005/000316 WO2005085868A1 (en) 2004-03-05 2005-03-03 Methods for identifying compounds capable of modulating the hydrolase activity of clca protien
EP05711171A EP1725875A1 (en) 2004-03-05 2005-03-03 Methods for identifying compounds capable of modulating the hydrolase activity of clca protien
US10/590,691 US20080233604A1 (en) 2004-03-05 2005-03-03 Methods For Identifying Compounds Capable of Modulating the Hydrolase Activity of Clca Protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0400564A SE0400564D0 (sv) 2004-03-05 2004-03-05 Methods

Publications (1)

Publication Number Publication Date
SE0400564D0 true SE0400564D0 (sv) 2004-03-05

Family

ID=32067334

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0400564A SE0400564D0 (sv) 2004-03-05 2004-03-05 Methods

Country Status (4)

Country Link
US (1) US20080233604A1 (sv)
EP (1) EP1725875A1 (sv)
SE (1) SE0400564D0 (sv)
WO (1) WO2005085868A1 (sv)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1067940A4 (en) * 1998-03-03 2003-01-02 Genaera Corp FACTORS ASSOCIATED WITH ASTHMA AS TARGETS FOR THE TREATMENT OF ATOPIC ALLERGIES INCLUDING ASTHMA AND RELATED DISORDERS
US20030059434A1 (en) * 2000-08-09 2003-03-27 Andrew Grupe Methods and compositions for treating gastrointestinal tract mucin production associated disease conditions
US7141365B2 (en) * 2001-05-18 2006-11-28 Syntex (U.S.A.) Llc Methods for diagnosing a mucin production associated disease condition

Also Published As

Publication number Publication date
US20080233604A1 (en) 2008-09-25
EP1725875A1 (en) 2006-11-29
WO2005085868A1 (en) 2005-09-15

Similar Documents

Publication Publication Date Title
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
WO2004041160A3 (en) Methods and animal model for analyzing age-related macular degeneration
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
NO20083324L (no) Multisykliske aminosyrederivater og anvendelse derav
EA201001695A1 (ru) Применение эпотилона d для лечения заболеваний, связанных с тау-белком
TW200833692A (en) Triazolopyridazine protein kinase modulators
ATE482213T1 (de) Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine
CY1112383T1 (el) Αναστολεις της πρωτεϊνης ενεργοποιησης της 5-λιποξυγενασης (flap)
CY1109551T1 (el) Πρωτεασωμικοι αναστολεις και μεθοδοι χρησιμοποιησης αυτων
ATE369333T1 (de) Sulfonamidderivate zur behandlung von krankheiten
NO20081084L (no) Arylpyridiner og fremgangsmater for deres anvendelse
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
DE602005020611D1 (de) Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen
ATE375977T1 (de) Sulfonamidderivate zur behandlung von krankheiten
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
ATE511645T1 (de) Testverfahren zum nachweis von antikörpern gegen lysosomenenzyme
NO20092741L (no) DR6-antagonister og anvendelse derav ved behandling av neurologiske forstyrrelser
ATE531388T1 (de) Verwendung von anti-alpha5beta1-antikörpern zur hemmung der krebszellproliferation
DK1348029T3 (da) Materialer og fremgangsmåder involveret i proteinaggregering i neurodegenerative sygdomme
EA200602154A1 (ru) Пиридин-4-илэтинилимидазолы и -пиразолы как антагонисты рецептора mglu5
WO2020176654A8 (en) Use of caseinolytic protease p function as a biomarker of drug response to imipridone-like agents
MXPA05009743A (es) Composiciones con actividad hematopoyetica e inmune.
ATE489628T1 (de) Galk1s als modifikatoren des pten/akt-wegs
MXPA05011157A (es) Nuevo metodo para modular la actividad relacionada a los huesos.
SE0400564D0 (sv) Methods